首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Anticoagulant activity screening of an in-house database of natural compounds for discovering novel selective factor Xa inhibitors; a combined in silico and in vitro approach
【24h】

Anticoagulant activity screening of an in-house database of natural compounds for discovering novel selective factor Xa inhibitors; a combined in silico and in vitro approach

机译:抗凝血活性筛选自然化合物内部数据库,用于发现新型选择性因子XA抑制剂; 在硅和体外方法中结合

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional edible natural products enclose a wealth of anticoagulants that can be prospected for new selective factor Xa inhibitors. Unlike multitargeted anticoagulants, selective factor Xa inhibitors effectively block coagulation cascade with a broader therapeutic window. In the present study, an in-house database comprises 3D structures of 1571 compounds from 26 natural products previously reported to enhance the bleeding tendency was compiled. Virtual screening (VS) of the constructed database to discover active FXa inhibitors was performed using sequential structure-based VS by Glide extra precision docking followed by ligand-based VS through pharmacophore modeling and 3D-QSAR. The implemented approach provoked liquorice, trifolium and olive as candidates for chromogenic in vitro FXa inhibitory assay with IC50 values of 0.363, 0.729, and 0.866 mg/mL, respectively. Evaluation of liquorice solvent fractions revealed that ethyl acetate fraction produced 97.93 +/- 0.019% inhibition of FXa. The adopted integrated strategy can be implemented for isolation of potent, selective nature-based FXa inhibitors.
机译:传统的食用天然产品包围了丰富的抗凝血剂,可以展望新的选择性因素XA抑制剂。与多目标抗凝血剂不同,选择性因子XA抑制剂有效地阻止凝固级联用更宽的治疗窗口。在本研究中,内部数据库包括来自预先报道的26个天然产物的1571种化合物的3D结构,以增强被编制的渗出趋势。通过Pharide额外精度对接,通过Pharmacophore建模和3D-QSAR,使用基于顺序结构的VS来执行构建数据库的虚拟筛选(VS)以发现有源FXA抑制器的基于顺序的VS。通过IC 50值为0.363,0.729和0.866mg / ml,实施的方法作为发色体,Trifolium和橄榄作为发色的体外FXA抑制试验的候选者。液体溶剂级分的评价显示,乙酸乙酯馏分产生97.93 +/- 0.019%FXA。采用的综合策略可用于分离有效的基于选择性的基于性的FXA抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号